This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Forma Therapeutics Holdings Future Growth
Future criteria checks 2/6
Key information
9.2%
Earnings growth rate
22.1%
EPS growth rate
Biotechs earnings growth | 20.8% |
Revenue growth rate | 83.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | n/a |
Recent future growth updates
Recent updates
We're Keeping An Eye On Forma Therapeutics Holdings' (NASDAQ:FMTX) Cash Burn Rate
Aug 30Forma Therapeutics GAAP EPS of -$1.10 misses by $0.11
Aug 05We're Hopeful That Forma Therapeutics Holdings (NASDAQ:FMTX) Will Use Its Cash Wisely
Mar 04We're Hopeful That Forma Therapeutics Holdings (NASDAQ:FMTX) Will Use Its Cash Wisely
Nov 20Here's Why We're Not Too Worried About Forma Therapeutics Holdings' (NASDAQ:FMTX) Cash Burn Situation
Aug 13We Think Forma Therapeutics Holdings (NASDAQ:FMTX) Needs To Drive Business Growth Carefully
Apr 18What Type Of Shareholders Own The Most Number of Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) Shares?
Jan 03Forma Therapeutics closes public offering priced at $45.25
Dec 16Forma Therapeutics prices equity offering at $45.25
Dec 11Forma Therapeutics' sickle cell treatment shows promising action at ASH presentation
Dec 08Forma Therapeutics EPS beats by $0.01
Nov 12Forma Therapeutics' sickle cell candidate an orphan drug in Europe
Nov 10Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 3 | -273 | N/A | N/A | 2 |
12/31/2023 | 9 | -218 | N/A | N/A | 2 |
12/31/2022 | 1 | -205 | N/A | N/A | 3 |
6/30/2022 | N/A | -190 | -175 | -170 | N/A |
3/31/2022 | N/A | -181 | -162 | -158 | N/A |
12/31/2021 | N/A | -173 | -154 | -150 | N/A |
9/30/2021 | N/A | -151 | -125 | -121 | N/A |
6/30/2021 | N/A | -136 | -113 | -112 | N/A |
3/31/2021 | N/A | -119 | -103 | -103 | N/A |
12/31/2020 | N/A | -74 | -96 | -95 | N/A |
9/30/2020 | 7 | -74 | -94 | -94 | N/A |
6/30/2020 | 11 | -78 | -95 | -95 | N/A |
3/31/2020 | 29 | -61 | -104 | -104 | N/A |
12/31/2019 | 101 | -53 | -35 | -34 | N/A |
12/31/2018 | 164 | 0 | -136 | -133 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FMTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: FMTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: FMTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: FMTX's revenue (83.8% per year) is forecast to grow faster than the US market (7.2% per year).
High Growth Revenue: FMTX's revenue (83.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if FMTX's Return on Equity is forecast to be high in 3 years time